الاسم واللقب: Cihangir EREM
مكان وتاريخ الميلاد: Ünye، 01.03.1960
المؤسسة التي يعمل بها حالياً: مستشفى إمبريال الخاص في طرابزون
متقاعد من كلية الطب بجامعة كارادينيز التقنية.

التعليم والتأهيل العلمي :

1978 تخرج من ثانوية Ünye
1985 تخرج من كلية الطب جراح باشا بجامعة إسطنبول
1992 أصبح اختصاصي أمراض باطنية في كلية الطب بجامعة كارادينيز التقنية
1998 أكمل برنامج التخصص الفرعي لمدة سنتين في قسم الغدد الصماء والأيض والتغذية، قسم الأمراض الباطنية، كلية الطب بجامعة إسطنبول.
2005 أكمل درجة الدكتوراه في الكيمياء الحيوية الطبية في كلية الطب بجامعة كارادينيز التقنية. .

الألقاب الأكاديمية: 1993–1996 أستاذ مساعد في قسم الأمراض الباطنية بكلية الطب بجامعة كارادينيز التقنية .
عمل كأستاذ مساعد في القسم.
1996 حصل على لقب أستاذ مشارك في الأمراض الباطنية.
تم تعيينه أستاذاً في 14 مارس 2003..

التخصص / القسم: شعبة أمراض الغدد الصماء والأيض، .
قسم الأمراض الباطنية. .

الحالة الاجتماعية: متزوج – لديه 4 أطفال اللغة الأجنبية: الإنجليزية

المؤسسات التي عمل بها:

1985-1988 الخدمة الإلزامية (طبيب في مركز الصحة في ماردين / مازيداغي ونائب مدير صحة ولاية ماردين) 1988-1992 باحث مساعد في كلية الطب بجامعة كارادينيز التقنية، قسم الأمراض الباطنية 1993-1996 أستاذ مساعد في كلية الطب بجامعة كارادينيز التقنية، قسم الأمراض الباطنية 1996-2002 أستاذ مشارك في كلية الطب بجامعة كارادينيز التقنية، قسم الأمراض الباطنية 2003-2016 أستاذ في كلية الطب بجامعة كارادينيز التقنية، قسم الأمراض الباطنية تقاعد من كلية الطب بجامعة كارادينيز التقنية بتاريخ 01.08.2017.

الدروس التي قام بتدريسها:.

منهجية التعامل مع مريض الغدد الصماء.

أمراض الوطاء (الهيبوثالاموس) والغدة النخامية.

أمراض لب الغدة الكظرية وورم القواتم.

أمراض قشرة الغدة الكظرية.

السمنة وعلاجها.

أمراض الغدة النخامية.

أمراض الغدة الدرقية.

فرط نشاط الغدة الدرقية وعلاجه.

فحص الجلد والأغشية المخاطية.

المنشورات العلمية: أكثر من 130 مقالة علمية دولية منشورة وأكثر من 120 مقالة وطنية، بالإضافة إلى عروض علمية وطنية ودولية.

عدد الاستشهادات العلمية الدولية: 43,487 (Google Scholar)، 26,935 (Scopus).
مؤشر H: 52 (Google Scholar)، 41 (Scopus).

أنشطة أخرى: .

عضوية جمعية الغدد الصماء والأيض التركية (TEMD) عضوية مجموعة العمل للغدة الدرقية والسمنة واضطرابات الدهون وارتفاع ضغط الدم التابعة لـ TEMD.
عضوية جمعية السكري والسمنة والتغذية.
عضو هيئة تحرير مجلة تركيا كلينيكس للغدد الصماء.
عضو هيئة تحرير مجلة Nobel Medikus.
عضوية الجمعية الأمريكية للغدد الصماء.

يُعد البروفيسور الدكتور Cihangir Erem أول أستاذ وأول اختصاصي في أمراض الغدد الصماء والأيض في منطقة شرق البحر الأسود. ومنذ عام 1995 قام بدراسة انتشار وعوامل الخطورة لأمراض السكري وارتفاع ضغط الدم وفرط شحميات الدم وتضخم الغدة الدرقية في منطقة شرق البحر الأسود، وذلك مع مجموعة البحث التي أسسها وأدارها (Trabzon Endocrinological Study Group). وقد استمرت هذه الأبحاث لمدة تزيد عن 20 عاماً ونُشرت في مجلات علمية وطنية ودولية مرموقة، مما جعله عالماً معروفاً في مجاله على مستوى تركيا وجامعة كارادينيز التقنية.

وقد لفتت هذه الأبحاث انتباه الباحثين في الولايات المتحدة والمملكة المتحدة الذين يعملون على نفس المواضيع، حيث قدموا عرضاً للتعاون العلمي مع عيادة أمراض الغدد الصماء والأيض في كلية الطب بجامعة كارادينيز التقنية. وبهذا أصبحت العيادة جزءاً من شبكات البحث العلمي الدولية مثل NCD Risk Factor Collaboration (NCD-RisC) ومجموعة Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating.

وخلال السنوات العشر الماضية استمر التعاون العلمي مع علماء من كلية الطب بجامعة هارفارد في الولايات المتحدة وكلية إمبريال لندن في المملكة المتحدة (Bin Zhou، Danaei Goardz، Majid Ezzati، Singh GM، Finucane MM، Mariachiara Di Cesare) حول الأمراض المذكورة أعلاه باستثناء تضخم الغدة الدرقية. وقد نُشرت هذه الدراسات منذ عام 2011 في مجلة Lancet (SCI, IF: 60.392) التي تُعد من أهم المجلات العلمية في العالم. ويُعد البروفيسور الدكتور Cihangir Erem أول عالم في تاريخ جامعة كارادينيز التقنية (تأسست عام 1955) تُنشر له مقالة علمية في هذه المجلة.

وفي أكتوبر 2020، ووفقاً لدراسة أجراها فريق بحثي بقيادة Ioannidis JPA من جامعة ستانفورد وبمشاركة علماء من الولايات المتحدة وهولندا، تم تقييم نحو 7 ملايين باحث نشروا ما لا يقل عن 5 مقالات علمية بين عامي 1996 و2019. ووفقاً لنتائج هذه الدراسة التي صنّفت أكثر 159,684 عالماً تأثيراً في العالم ضمن 22 مجالاً علمياً رئيسياً و176 تخصصاً فرعياً، تم إدراج البروفيسور الدكتور Cihangir Erem ضمن قائمة “أكثر العلماء تأثيراً في العالم”. ومن بين 857 أكاديمياً من جامعات مختلفة في تركيا و23 عضو هيئة تدريس من جامعة كارادينيز التقنية، كان Prof. Dr. Cihangir Erem الأكاديمي الوحيد من كلية الطب بجامعة كارادينيز التقنية الذي دخل القائمة، حيث احتل المرتبة 2083 عالمياً في مجاله البحثي والمرتبة الرابعة في تركيا. كما أن ثلاثة أكاديميين فقط متخصصين في الغدد الصماء والأيض في تركيا تمكنوا من دخول هذه القائمة. وقد نجح Prof. Dr. Cihangir Erem في دخول هذه القائمة خمس مرات متتالية بين الأعوام 2020 و2024. وقبل تقاعده من جامعة كارادينيز التقنية، كان ضمن المراتب الأولى بين 1040 عضو هيئة تدريس في الجامعة، كما احتل المرتبة الأولى بين 250 عضو هيئة تدريس في كلية الطب.

قائمة المنشورات I- المقالات الدولية

1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024 Nov 23;404(10467):2077-2093.  

4

2. NCD Risk Factor Collaboration (NCD-RisC). General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants. Lancet. 2024 Aug 31;404(10455):851-863.

3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024 Mar 16;403(10431):1027-1050.

4. NCD Risk Factor Collaboration (NCD-RisC). Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c. Nat Med. 2023 Nov;29(11):2885-2901.  

5. NCD Risk Factor Collaboration (NCD-RisC). Diminishing benefits of urban living for children and adolescents' growth and development. Nature. 2023 Mar;615(7954):874- 883.

6. Nuhoglu İ, Deger O, Topbaş M, Erem C. The prevalence of diabetes and associated risk factors among adult population in a Turkish population (Trabzon city). Prim Care Diabetes. 2022;16(4):549-554.

7. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304): 957-980.

8. NCD Risk Factor Collaboration (NCD-RisC). Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. Elife. 2021; 10:e60060.

9. NCD Risk Factor Collaboration (NCD-RisC). Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants. Lancet. 2020; 396(10261): 1511-1524.

5

10. NCD Risk Factor Collaboration (NCD-RisC). Repositioning of the global epicentre of non-optimal cholesterol. Nature. 2020; 582(7810): 73-77.

11. NCD Risk Factor Collaboration (NCD-RisC). Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature. 2019;569 (7755): 260- 264.

12. NCD Risk Factor Collaboration (NCD-RisC). Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int J Epidemiol. 2018; 47(3): 872–883i.

13. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017; 390(10113):2627-2642.

14. Türk A, Mollamehmetoğlu S, Alver A, Menteşe A, Nuhoğlu İ, Erem C, İmamoğlu Hİ. The Relationship between Serum Carbonic Anhydrase I-II Autoantibody Levels and Diabetic Retinopathy in Type 1 Diabetes Patients. Turk J Ophthalmol. 2017; 47(2):85-88.

15. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017; 389(10064): 37-55.
16. NCD Risk Factor Collaboration (NCD-RisC). A century of trends in adult human height. Elife. 2016; 5. pii: e13410.
17. Erem C, Suleyman AK, Civan N, Mentese A, Nuhoglu İ, Uzun A, Coskun H, Deger O. The effect of L-thyroxine replacement therapy on ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hypothyroidism. Endocr Res. 2016; 41(4): 350-360.

6

18. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387(10027): 1513-30.

19. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016; 387(10026):1377- 1396.
20. Erem C, Civan N, Coskun H, Mentese A, Suleyman AK, Altay DU, Akgul Z, Deger O. Signal peptide-CUB-EGF domain-containing protein 1 (SCUBE1) levels in patients with overt and subclinical hyperthyroidism: effects of treatment. Clin Endocrinol(Oxf). 2016; 84(6): 919-24.
21. Erem C. Prevalence of Overweight and Obesity in Turkey. IJC Metabolic & Endocrine . 2015; 8: 38-41.
22. NCD Risk Factor Collaboration (NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population- based studies with 331,288 participants. Lancet Diabetes Endocrinol. 2015; 3(8): 624-37.

23. Erem C, Kuzu UB, Deger O, CanG. Prevalence of gestational diabetes mellitus and associated risk factors in Turkish women: The Trabzon GDM Study.  Archives of Medical Science . 2015; 11(4): 724-735.

24. Erem C, Suleyman AK, Civan N, Mentese A, Nuhoglu I, Uzun A, Ersoz HO, Deger O. Ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hyperthyroidism: effects of treatment on oxidative stress. Endocr J. 2015; 62(6): 493-501.

25. Usta A, Alhan E, Cinel A, Türkyılmaz S, Erem C. A 20-Year Study on 190 Patients With Primary Hyperparathyroidism in a Developing Country: Turkey Experience. Int Surg. 2015; 100: 648-55.

7

26. Ilter A, Kırış A, Kaplan S, Kutlu M, Sahin M, Erem C, Civan N, Kangül F. Atrial conduction times and left atrium mechanical functions in patients with active acromegaly. Endocrine. 2015; 48(2):653-60.

27. Kural B, Değer O, Erem C, Balaban Yücesan F, Aliyazicioğlu R, Barlak Y. Is the combined use of insulin resistance indices, including adipokines, more reliable in metabolic syndrome? Turk J Med Sci. 2014;44(6):1021-8.

28. Civan N, Erem C, Coskun H, Kocak M, Nuhoglu I, Ersoz HO. Hypoparathyroidism, deafness, and renal dysplasia. Acta Endocrinol-Bucharest. 2014; 10(4): 687-692. 

29. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014; 2(8): 634-47.

30. Erem C, Fidan M, Civan N, Cobanoglu U, Kangul F, Nuhoglu I, Alhan E. Hormone- secreting large adrenal ganglioneuroma in an adult patient: a case report and review of literature. Blood Press. 2014; 23(1):64-9.

31. Erden ES, Genc S, Motor S, Ustun I, Ulutas KT, Bilgic HK, Oktar S, Sungur S, Erem C, Gokce C. Investigation of serum bisphenol A, vitamin D, and parathyroid hormone levels in patients with obstructive sleep apnea syndrome. Endocrine. 2014; 45(2): 311-8.

32. Kocak M, Erem C, Deger O, Topbas M, Ersoz HO, Can E. Current prevalence of goiter determined by ultrasonography and associated risk factors in a formerly iodine- deficient area of Turkey. Endocrine. 2014; 47 (1): 290-98.

33. Erem C, Civan N, Fidan M, Cobanoglu U, Kangül F, Fural AM. Warthin-Like Papillary Thyroid Carcinoma: Report of a New Case. Acta Endocrinol-Bucharest. 2014, 10 (2): 293-298.

8

34. Erem C, Civan N., Fidan M., Cobanoglu U., Kangül F., Ersoz H.O., Alhan E. Composite Adrenal Pheochromocytoma-Ganglioneuroma in an Adult Patient. Acta Endo (Buc) 2014, 10 (1): 140-149.

35. Erem C, Ozbas HM, Nuhoglu I, Deger O, Civan N, Ersoz HO. Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2014 May;122(5):295-302.

36. Erem C. Update on idiopathic hirsutism: diagnosis and treatment. Acta Clin Belg. 2013 Jul-Aug;68(4):268-74.
37. Kural BV, Deger, O, Erem C et al. Sequence Variant in the LPIN1 gene in Patients with Metabolic Syndrome. Turk J Biochem. 2013; 38 (3): 280-85.
38. Deger O, Yandi YE, Ayvaz M, Erem C, Hacıhasanoğlu AB. Polymorphisms in ABC transporters (ABCA1 and ABCC8) in metabolic syndrome. Turk J Med Sci. 2013; 43 (2): 214-221.
39. Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F,Stevens GA, Riley LM, Lu Y, Rao M, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group. The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation. 2013;127(14):1493- 502.

40. Kırış A, Erem C, Turan OE, Civan N, Kırış G, Nuhoğlu I, Ilter A, Ersöz HO, Kutlu M. Left ventricular synchronicity is impaired in patients with active acromegaly. Endocrine. 2013 Aug;44(1):200-6.

41. Erem C, Civan N. Extensive cerebral calcification and pulmonary bullae in a patient with ehlers-Danlos syndrome. Acta Endocrinol-Bucharest. 2012; 8(4): 645-650.

9

42. Erem C, Ucuncu O, Nuhoglu I, Turkyilmaz S, Yildiz K, Civan N, Akcay M. Large Adrenocortical Oncocytoma with Uncertain Malignant Potential: Report of a New Case and review of the Literature. Acta Endocrinol-Bucharest. 2012; 8: 295-306.

43. Kırış A, Erem C, Kırış G, Nuhoğlu I, Karaman K, Civan N, Orem C, Durmuş I, Kutlu M. The assessment of left ventricular systolic asynchrony in patients with primary hyperparathyroidism. Echocardiography. 2011 Oct;28(9):955-60.

44. Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C. Correspondence. Retina. 2011 Sep 12. [Epub ahead of print]

45. Sonmez B, Erem C, Dogan I, Ersoz HO, Sonmez M. Efficacy of low and high fixed dose radioactive iodine therapy in patients with toxic nodular goiter. Minerva Endocrinol. 2011 Jun;36(2):117-21.
46. Fidan E, Onder Ersoz H, Yilmaz M, Yilmaz H, Kocak M, Karahan C, Erem C. The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol. 2011 Dec;48 (4):297-302.

47. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, Farzadfar F, Stevens GA, Lim SS, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet. 2011 Feb 12;377(9765):568-77.

48. Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C. The relationship between diabetic retinopathy and serum levels of ischemia-modified albümin and malondialdehyde. Retina. 2011; 31: 602-608.

49. Erem C. Thyroid disorders and hypercoagulability. Semin Thromb Hemost. 2011 Feb;37(1):17-26.

10

50. Kırış A, Erem C, Kırış G, Koçak M, Gedikli O, Nuhoğlu I, Kutlu M, Kaplan T, Gökçe M, Celik S. Intra-left ventricular systolic asynchrony in patients with overt hyperthyroidism. Endocrine. 2010 Oct;38(2):283-8.
51. Erem C, Kocak M, Nuhoglu I, Yılmaz M, Ucuncu O. Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma. Clin Endocrinol (Oxf). 2010 Oct;73(4):502-7.
52. Erem C, Kocak, M; Ersoz, HO, et al. Hypertension, Diabetes, Hypokalemia, and Metabolic Alkalosis Cushing Syndrome Secondary to Ectopic Adrenocorticotropic Hormone Secretion From Prostate Adenocarcinoma . Endocrinologist.  2010; 20: 211- 13.
53. Erem C. A Case of Pituitary Hyperplasia Secondary to Primary Hypothyroidism Presenting With Irregular Menses, Galactorrhea, and Hyperprolactinemia . Endocrinologist.  2010; 20: 168-70.   
54. Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I, Ersoz HO. Increased thrombin- activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism. Endocrine. 2009; 36: 473-78.
55. Erem C, Kocak M, Nuhoglu I, Cobanoglu U, Ucuncu O, Okatan BK. Primary thyroid paraganglioma presenting with double thyroid nodule: a case report. Endocrine. 2009; 36: 368-71.

56. Ukinc K, Eminagaoglu S, Ersoz HO, Erem C, Karahan C, Hacihasanoglu AB, Kocak M. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine. 2009; 36: 425-32.

57. Kaplan S, Kırış A, Erem C, Kaplan T, Kırış G, Gedikli O, Koçak M, Baykan M, Celik S. Assessment of Left Ventricular Systolic Asynchrony in Patients with Clinical Hypothyroidism. Echocardiography. 2010 Feb;27(2):117-22.

58. Unluhizarci K, Kula M, Dundar M, Tanriverdi F, Israel S, Colak R, Dokmetas HS, Atmaca H, Bahceci M, Balci MK, Comlekci A, Bilen H, Akarsu E, Erem C,

11 Kelestimur F. The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism. Gynecol Endocrinol. 2010; 26: 139-143.

59. Ukinc K, Ersoz HO, Karahan C, Erem C, Eminagaoglu S, Hacihasanoglu AB, Yilmaz M, Kocak M. Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine. 2009 Oct;36(2):255-61.
60. Erem C, Nuhoglu I, Yilmaz M, Kocak M, Demirel A, Ucuncu O, Onder Ersoz H. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. J Endocrinol Invest. 2009 Feb;32(2):169-74.
61. Erem C, Ucuncu O, Nuhoglu I, Cinel A, Cobanoglu U, Demirel A, Koc E, Kocak M, Guvendi GF. Adrenal ganglioneuroma: report of a new case. Endocrine. 2009 Jun;35(3):293-6.
62. Erem C. Coagulation and fibrinolysis in thyroid dysfunction. Endocrine. 2009 Aug;36 (1):110-8.
63. Baykan M, Erem C, Gedikli O, Hacihasanoglu A, Erdogan T, Kocak M, Kaplan S, Korkmaz L, Celik S. Impairment in flow-mediated vasodilatation of the brachial artery in acromegaly. Med Princ Pract. 2009;18(3):228-32.
64. Ukinc K, Ersoz HO, Erem C, Hacihasanoglu AB, Karti SS. Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients. Endocrine. 2009 Jun;35(3):380-8.
65. Erem C, Kocak M, Nuhoglu I, Yilmaz M, Ucuncu O. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin- activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism. Eur J Endocrinol. 2009 May;160(5):863-8.
66. Alver, A, Menteşe A, Erem C, Değer, Koçak M, Keha E. Serum carbonic anhydrase autoantibodies in metabolic syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2009: 3 (4): 211-13.

12

67. Erem C, Nuhoglu I, Kocak M, Yilmaz M, Sipahi ST, Ucuncu O, Ersoz HO. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI. Endocrine. 2008 Jun;33(3):270-6.
68. Ukinc K, Ersoz HO, Erem C, Hacihasanoglu AB. Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome. Endocrine. 2009 Feb;35(1):123-9.
69. Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine. 2008 Aug-Dec;34(1-3):36-51.
70. Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I, Ersoz HO. Increased thrombin- activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism. Endocrine. 2009 Feb;35(1):75-80.

71. Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health (Oxf). 2008; 31(1):47-58.

72. Erem C, Kocak M, Hacihasanoglu A, Yilmaz M. Blood coagulation and fibrinolysis in male patients with hypogonadotropic hypogonadism: plasma factor V and factor X activities increase in hypogonadotropic hypogonadism. J Endocrinol Invest. 2008 Jun;31(6):537-41.

73. Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO. Blood Coagulation, Fibrinolysis and Lipid Profile in Patients with Primary Hyperparathyroidism: Increased Plasma Factor VII and X Activities and D-Dimer Levels. Exp Clin Endocrinol Diabetes. 2008; 116(10):619-24.

74. Ersoz S, Sert H, Yandi M, Erem C, Mungan S, Ersoz HO, Cobanoglu U, Hacihasanoglu A. The Significance Of Galectin-3 Expression in the Immunocytochemical Evaluation of Thyroid Fine Needle Aspiration Cytology. Pathol Oncol Res. 2008; 14(4):457-60.

13

75. Erem C, Hacihasanoglu A, Deger O, Topbas M, Hosver I, Ersoz HO, Can G. Prevalence of Metabolic Syndrome and Associated Risk Factors Among Turkish Adults: Trabzon MetS Study. Endocrine. 2008; 33(1):9-20.

76. Baykan M, Erem C, Gedikli O, Hacihasanoglu A, Erdogan T, Kocak M, Kaplan S,Kiriş A, Orem C, Celik S. Assessment of Left Ventricular Diastolic Function and Tei Index by Tissue Doppler Imaging in Patients with Cushing's Syndrome. Echocardiography. 2008 Feb;25(2):182-90.

77. Baykan M, Erem C, Gedikli O, Hacıhasanoğlu A, Erdoğan T, Koçak M, Kaplan S, Kırış A, Celik S. Assessment of the Tei Index by Tissue Doppler Imaging in Patients with Acromegaly: Serum Growth Hormone Level Is Associated with the Tei Index. Echocardiography. 2008; 25: 374-380.

78. Erem C, Kocak M, Cinel A, Ersoz HO, Reis A. Dopamine-secreting adrenal ganglioneuroma presenting with paroxysmal hypertension attacks. Saudi Med J. 2008 Jan;29(1):122-5.

79. Ukinc K, Ersoz HO, Erem C, Hacihasanoglu A, Ersoz S, Buran M. Pachydermoperiostosis with gynecomastia and osteoporosis: a rare case with a rare presentation. Int J Clin Pract. 2007 Nov;61(11):1939-40. No abstract available.

80. Baykan M, Erem C, Gedikli O, Hacihasanoglu A, Erdogan T, Kocak M, Durmuş I, Korkmaz L, Celik S. Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's Syndrome. Endocrine. 2007 Jun;31(3):300-4.

81. Kaynar K, Ozkan G, Erem C, Gul S, Yilmaz M, Sonmez B, Ozdemir F, Ulusoy S. An unusual etiology of erythropoietin resistance: hyperthyroidism. Ren Fail. 2007;29(6):759-61. PMID: 17763175 [PubMed - indexed for MEDLINE]

82. Alver A, Mentese A, Karahan SC, Erem C, Keha EE, Arikan MK, Eminagaoglu MS, Deger O. Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease. Exp Clin Endocrinol Diabetes. 2007; 115: 287-91.

14

83. Isik AC, Imamoglu M, Erem C, Sari A. Paragangliomas of the head and neck. Med Princ Pract. 2007; 16: 209-14.

84. Baykan M, Erem C, Erdogan T, Ersoz HO, Gedikli O, Korkmaz L, Kucukosmanoglu M, Haclhasanoglu A, Kaplan S, Celik S. Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf). 2007; 66: 483-88.

85. Baykan M, Erdogan T, Erem C, Hacihasanoglu A, Gedikli O, Kucukosmanoglu M, Celik S, Orem C. The relationship between flow-mediated dilatation and left ventricular function in type 2 diabetic patients with microalbuminuria. Endocrine. 2006; 30: 197-202.

86. Erem C, Deger O, Ovali E, Barlak Y. The effects of royal jelly on autoimmunity in Graves' disease. Endocrine. 2006; 30: 175-83.

87. Erem C, Onder Ersoz H, Ukinc K, Hacihasanoglu A, Alhan E, Cobanoglu U, Kocak, M, Erdol H. Neurofibromatosis type 1 associated with pheochromocytoma: a case report and a review of the literature. J Endocrinol Invest. 2007; 30: 59-64.

88. Erem C, Ersoz HO, Ukinc K, Avunduk AM, Hacihasanoglu A, Kocak M. Acromegaly presenting with diabetic ketoacidosis, associated with retinitis pigmentosa and octreotide-induced bradycardia: a case report and a review of the literature. Endocrine. 2006; 30: 145-49.

89. Baykan M, Erem C, Erdogan T, Hacihasanoglu A, Gedikli O, Kiris A, Kucukosmanoglu M, Ersoz HO, Celik S. Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int J Cardiovasc Imaging. 2007; 23: 323-28.

90. Celik S, Erdogan T, Gedikli O, Kiris A, Erem C. Diagonal ear-lobe crease is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease. Atherosclerosis. 2007; 192: 428-31.

15

91. Erem C, Hacihasanoglu A, Cinel A, Isik AC, Reis A, Sari A, Ersoz HO, Ukinc K. Carotid body tumors and adrenal pheochromocytomas in siblings of a Turkish family. Med Princ Pract. 2006;15: 396-400.

92. Ersoz HO, Ukinc K, Kose M, Erem C, Gunduz A, Hacihasanoglu AB, Karti SS. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. Int J Clin Pract. 2006; 60: 429-33.

93. Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf). 2006; 64: 323-29.

94. Isik AC, Erem C, Imamoglu M, Cinel A, Sari A, Maral G. Familial Paraganglioma. Eur Arch Oto-Rhino-L. 2006 Jan;263(1):23-31.

95. Erem C, Kocak M, Onder Ersoz H, Ersoz S, Yucel Y. Epinephrine-secreting cystic pheochromocytoma presenting with an incidentaladrenal mass: a case report and a review of the literature. Endocrine. 2005; 28: 225-30.

96. Erem C, Hacihasanoglu A, Ersoz HO, Reis AK, Calik A, Ukinc K, Kocak M. Pheochromocytoma combinated with preclinical Cushing’s Syndrome in the same adrenal gland. J Endocrinol Invest. 2005; 28: 561-65.

97. Erem C, Celik F, Reis AK, Hacihasanoglu A, Gör A. Large Adrenal Pseudocyst Presenting with Epigastric Distress and Abdominal Distention. Med Princ Pract. 2005; 14: 284-87.

98. Erem C. Thyrotoxic hypokalemic periodic paralysis in a Turkish male with Graves' disease: a rare case report and review of the literature. Endocrine. 2005; 27: 63-65.

16

99. Erem C, Yucel Y, Yasar Z, Reis AK, Kocak M, Hacihasanoglu A. Leukocytoclastic vasculitis: a rare manifestation of propylthiouracil hypersensitivity. Med Princ Pract. 2005; 14: 366-69.

100. Sayarlioglu H, Erkoc R, Dogan E, Topal C, Algun E, Erem C, Atmaca H, Kocak E, Yilmaz R, Erdol H, Cınal A. Nephropathy and retinopathy in type 2 diabetic patients living at moderately high altitude and sea level. Ren Fail. 2005; 27: 67-71.

101. Erem C, Hacihasanoglu A, Celik S, Ovali E, Ersoz HO, Ukinc K, Değer O, Telatar M. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med Princ Pract. 2005; 14: 22-30.

102. Erem C, Hacihasanoglu A, Cinel A, Cobanoglu U, Ersoz HO, Ahmetoglu A, Ukinc K, Kocak M. Adrenal Black Adenoma Associated with Cushing’s Syndrome. Endocrine. 2004; 25: 253-58.

103. Erem C, Hacihasanoglu A, Sari A, Reis A, Alhan E, Cobanoglu U, Ersoz HO, Ukinc K. Intrathyroidal papillary thyroid carcinoma presenting with a solitary brain metastasis. Endocrine. 2004; 25: 187-94.

104. Erem C, Hacihasanoglu A, Sari A, Onder Ersoz H, Ukinc K, Fidan S. A Rare Case and a Rapid Tumor Response to Therapy: Dramatic Reduction in Tumor Size During Octreotide Treatment in a Patient with TSH-Secreting Pituitary Macroadenoma. Endocrine. 2004; 25: 141-46.

105. Erem C, Kandemir N, Hacihasanoglu A, Ersoz HO, Ukinc K, Kocak M. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome. Endocrine. 2004; 25: 55-60.

106. Ulusoy S, Ovali E, Aydin F, Erem C, Ozdemir F, Kaynar K. Hemostatic and fibrinolytic response to nasal desmopressin in hemodialysis patients. Med Princ Pract. 2004; 13: 340-45.

17

107. Erem C, Arslan C, Hacihasanoglu A, Deger O, Topbas M, Ukinc K, Ersoz HO, Telatar M. Prevalence of obesity and associated risk factors in a Turkish population (Trabzon city, Turkey). Obes Res. 2004;12: 1117-27.

108. Erem C, Hacihasanoglu A, Cinel A, Ersoz HO, Reis A, Sari A, Kose M, Ukinc K, Telatar M.Sphenoid sinus brown tumor, a mass lesion of occipital bone and hypercalcemia: an unusual presentation of primary hyperparathyroidism. J Endocrinol Invest. 2004; 27: 366-69.

109. Ersoz HO, Ukinc K, Baykan M, Erem C, Durmus I, Hacihasanoglu A, Telatar M. Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study. Int J Obes Relat Metab Disord. 2004; 28: 378-83.

110. Erem C, Kavgaci H, Ersoz HO, Ukinç K, Hacıhasanoglu H, Kartı SS, Değer O, Telatar M. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract. 2003; 57: 78-81.

111. Erem C, Algün E, Özbey N, Azezli A, Aral F, Orhan Y, Molvalılar S, Sencer E. Clinical and Laboratory Findings and Results of Therapy in 55 Patients with Cushing’s Syndrome. J Endocrinol Invest. 2003; 26: 65-72.

112. Erem C, Cihanyurdu N, Deger O, Karahan C, Can G, Telatar M. Screening for gestational diabetes mellitus in northeastern Turkey (Trabzon city). Eur J Epidemiol. 2003; 18: 39-43.

113. Boz C, Velioğlu S, Altunayoğlu V, Özmenoğlu M, Erem C. Central nervous system involvement in autoimmune polyglandular sydrome. Clin Neurol Neurosurg. 2003; 105: 102-104.

114. Kavgaci H, Sahin A, Ersoz HO, Erem C, Ozdemir F. The effects of losartane and fosinopril in hypertensive type 2 diabetic patients. Diab Res Clin Prac. 2002; 58: 19-25.

18

115. Erem C, Ersoz HO, Kartı SS, Ukinç K, Hacıhasanoglu A, Değer O, Telatar M. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest. 2002; 25: 345-350.

116. Erem C, Tanakol R, Alagöl F, Ömer B, Çetin Ö. Relationship of Bone Turnover Parameters, Endogenous Hormones and Vit D Deficiency to Hip Fracture in Elderly Postmenopausal Women. Int J Clin Pract. 2002; 56: 333-337.

117. Erem C, Yildiz R, Kavgacı H, Karahan C, Deger O, Can G, Telatar M. Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city). Diab Res Clin Prac. 2001; 54: 203-208.

118. Erem C, Kavgaci H, Karahan C, Mocan MZ, Telatar M.Thyroid function tests in pregnant women with and without goiter in the eastern Black Sea region. Gynecol Endocrinol. 2001; 15:293-97.

119. Celik S, Erdol C, Erem C, Baykan M, Gokce M, Durmus I. Echocardiographic evaluation in patients with hypogonadotropic hypogonadism. J Reprod Med. 2001; 46: 709-11.

120. Vanizor B, Orem A, Karahan SC, Kiran E, Erem C, Aliyazicioglu R, Uydu HA. Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications. Diabetes Res Clin Pract. 2001; 54:33-39.

121. Karahan SC, Deger O, Orem A, Ucar F, Erem C, Alver A, Onder E. The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus. Clin Chem Lab Med. 2001;39: 109-15.

122. S.C Karahan, A. Örem, O. Değer, Erem C, Y. Aliyazıcıoğlu, S. Yildirmiş, F. Özdemir. Plasma Polymorphonuclear elastase: A good indicator for vascular complications in patients with NIDDM ?. Diabetes Research. 2000;35:001-009.

19

123. Erem C, Uslu T, Deger O, Tosun M, Kavgaci H. Increased plasma lipoprotein (a) concentrations in Behcet's disease and its relation to vascular events. Heart. 2000; 84 :208-9.

124. Erem C, Deger O, Bostan M, Orem A, Sonmez M, Ulusoy S, Telatar M. Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications. Acta Cardiol. 1999;54:203-7.

125. Erem C, Deger O, Bostan M, Orem A, Sonmez M, Ulusoy S, Telatar M. Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects. Acta Cardiol. 1999; 54: 77-81.

126. Mocan MZ, Erem C, Ulusoy S. Urinary cAMP activity in chronic renal failure. Int Urol Nephrol. 1998; 30: 215-22.

127. Erem C, Unal M, Serce K, Baki AH, Tufan U, Harova G. What is your diagnosis? Int Urol Nephrol. 1998; 30: 49-51.

128. Erem C, Kulan K, Tuncer C, Bostan M, Mocan Z, Komsuoglu B. Cardiac arrhythmias in patients on maintenance hemodialysis. Acta Cardiol. 1997; 52: 25-36.

129. Uslu T, Erem C, Tosun M, Deger O. Plasma endothelin-1 levels in Behcet's disease. Clin Rheumatol. 1997; 16: 59-61.

130. Erem C, Savaşkan H, Çağılcı F, Değer O, Karahan C, Korkmaz H, Ulusoy Ş, Sönmez M, Cihanyurdu N, Telatar M. Plasma Endothelin-1 Levels in Patients With Type II Diabetes Mellitus. Diabetes Research. 1996; 31: 105-111

131. Efe H, Erem C, Değer O, Aliyazıcıoğlu Y, Örem A, Yıldırmış S. Plasma Malondialdehyde Levels in NIDDM Patients: Relationship with Glycosylated Hemoglobin and HDL-C. Diabetes Research. 1996 ;31:137-147.

132. Erem C, Ünal M, Telatar M, Serçe K, Turgutalp H. Insulinoma and Primary Hypothyroidism. Diabetes Research. 1996; 31: 83-90.

20

133. Tosun M, Guler M, Erem C, Uslu T, Miskioglu E. Intermittent polyarthritis due to propylthiouracil. Clin Rheumatol. 1995; 14: 574-75.

134. Mocan MZ, Erem C, Telatar M. Urinary iodine levels in pregnant women with and without goiter in the Eastern Black Sea part of Turkey. Trace Elements and Electrolytes.1995; 12: 195-197.

135. Unal M, Tuncer C, Serce K, Bostan M, Erem C, Gokce M. A cardiac giant hydatid cyst of the interventricular septum masquerading as ischemic heart disease: role of MR imaging. Acta Cardiol. 1995; 50: 323-6.

136. Unal M, Tuncer C, Serce K, Bostan M, Gokce M, Erem C. Non-valvular main pulmonary artery vegetation associated with aortopulmonary window. Acta Cardiol. 1995; 50: 241-44.

137. Erem C, Kulan K, Goldeli O, Tuncer C, Komsuoglu B, Mocan M. Impact of hemodialysis on QT interval. Acta Cardiol. 1995; 50: 177-85.

138. Unal M, Erem C, Serce K, Tuncer C, Bostan M, Gokce M. The presence of both horseshoe and a supernumerary kidney associated with coarctation of aorta. Acta Cardiol. 1995; 50: 155-60.
139. Mocan Z, Erem C, Yildirim M, Telatar M, Deger O. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy. Diabetes Res. 1994; 26: 101-7.

II- المقالات الوطنية

1- Cihangir Erem, Nadim Civan, Mehmet Fidan, Ümit Çobanoğlu, Fevzi Kangül, Hülya Coşkun, İdris Yıldız. A clinically silent pheochromocytoma combined with subclinical Cushing’s syndrome in the same adrenal gland: A case report and review of literatüre. Nobel Med 2017; 13(1): 74-80.

21 2- Nadim Civan, Cihangir Erem, İrfan Nuhoğlu, Hülya Coşkun, Halil Önder Ersöz, Mustafa Koçak, Asım Örem, Ayşegül Yılmaz. Cardiac troponin I is not increased in severe acute hypothyroidism in patients with differentiated thyroid carcinoma. Nobel Med 2016; 12(3): 47-50. 3- Ükinç K, Erem C, Ersöz HÖ, Hacıhasanoğlu A, Ersöz Ş, Fidan E. Vaka Sunumu: Prostat Adenokarsinomu ve Ektopik ACTH Sendromu. Turkiye Klinikleri J Med Sci 2006, 26:699- 703. 4- Hacıhasanoğlu AB, Koçak M, Ükinç K, Erem C, Ersöz HÖ, Erdöl H, Telatar M: Primer gonadal yetmezlik ile birlikte seyreden Wolfram Sendromu (Olgu sunumu). Türkiye Klinikleri Endokrinoloji 2(3):213–216;2004. 5- K. Ükinç, H.Ö. Ersöz, C. Erem, S. Kartı, M. Telatar. Diyabetik hastalarda mikro ve makrovasküler komplikasyonların göstergesi olarak CRP, fibrinojen ve ferrritin düzeyleri. Türk Diyabet Yıllığı 2001-2002. S.199-209. 6- C.Erem, E. Algün, N. Özbey, A. Azezli, F. Aral, Y. Orhan, S. Molvalılar, E. Sencer. Basedow-Graves hastalığında radyoaktif ilaç tedavisinin sonuçları. İst. Tıp Fak. Mecmuası. 2001; 63 (1): 41-47. 7- E.A.Çakmak, C.Erem, T.Fıstık, M. Solak, S. Şimşek, Ü.Tufan, H. Savaşkan. Obes olgularda dermoglifik analizler: İlk bulgular. Kocaeli Tıp Dergisi. 2001; 2:95-101. 8- H. Kavgacı, AH. Baki, C. Erem. Akut böbrek yetmezliğinde yaş prognoz ilişkisi. Klinik Bilimler Doktor. 2000; 6 (2): 161-64. 9- C.Erem, E. Algün, N. Özbey, A. Azezli, F. Aral, Y. Orhan, S. Molvalılar, E. Sencer. Cushing sendromu: kırk beş olgunun klinik ve laboratuvar bulguları ve tedavi sonuçları ile değerlendirilmesi. İst. Tıp Fak. Mecmuası. 1999; 62 (3): 237-42. 10- M. Adaş, R. Tanakol, S. Yarman, C. Erem, H. Boztepe, F. Alagöl, H. Azizlerli, Ö. Sandalcı. Acil metabolik ve nörolojik hastalıkların ayırıcı tanısında porfiria. İst. Tıp Fak. Mecmuası. 1999; 62 (2): 200-207. 11- H. Kavgacı, A. Baki, C. Erem. Akut böbrek yetmezliğinde prognoza etkili faktörler. T Klin Tıp Bilimleri. 1999; 19: 358-361. 12- C. Erem, Ş. Ulusoy, A. Örem, M. Sönmez, O. Değer, H. Kavgacı. Prediyaliz ve kronik hemodiyaliz hastalarında plazma lipoprotein (a) seviyeleri. Karadeniz Tıp Dergisi. 1999; 12: 6-8.

22 13- C. Erem, R. Tanakol. Tiroid hastalıklarında koagülasyon bozuklukları. Aktüel Tıp Dergisi. 1998; 3(6): 308-12. 14- T. Uslu, M. Güler, M. Tosun, C. Erem. Clinical characteristics of patients with Ankylosing spondylitis. Türkiye Tıp Dergisi. 1997; 4. 29-32. 15- C. Erem, H. Kavgacı, T. Uzun, M. Telatar, K. Serçe. Uyumsuz bir primer hiperparatiroidi vakası. MN Doktor. 1996; 4: 123-26. 16- Ş. Ulusoy, F. Aydın, R. Yıldız, C. Erem. Down sendromu ve akut lösemi (Olgu sunumu). Acta Oncologica Turcica. 1996; 3-4: 148-50. 17- C. Erem, Ş. Ulusoy, E. Ovalı, Z. Mocan, M. Telatar. Kronik Hemodiyaliz Hastalarında Hemostaz ve Hemodiyalizin Hemostaz Üzerine Etkisi. Türk Hematoloji-Onkoloji Dergisi (THOD). 1996; 6:69-76. 18- T.Uslu, M.Tosun, N. Hansu, C. Erem, M. Güler. Romatoid Artritli ve Fibromiyalji Sendromlu Kadın Hastalarda Kan Testosteron Seviyeleri. Tıbbi Rehabilitasyon Kurumu Derneği. 1996 ;7:85-88. 19- T.Uslu, M.Tosun , C. Erem, N. Hansu, M. Güler. Romatoid Artritli ve Fibromiyalji Sendromlu Kadın Hastalarda Plazma Prolaktin Seviyeleri. Fizik Tedavi ve Rehabilitasyon Derneği. 1996; 7:15-17. 20- C. Erem, E. Akyılmaz, E.Ovalı, Ş Ulusoy, MZ. Mocan. Akut Böbrek Yetersizliği olan hastalarda idrar endotelin eksresyonu. Yeni Tıp Dergisi. 1996; 13: 5- 21- MZ. Mocan, H. Kavgacı, C. Erem, H. Mocan. The Influence of Essential Amino Acid Supplementation for the Improvement of Acute Renal Failure. T J Med Sci .1996; 26: 271-75. 22- MZ. Mocan, B. Çetinarslan, C. Erem, M. Telatar. The Effect of Hyperthyroidism on Renal Function. Turkish Journal of Medical Research. 1995;13:28-30. 23- M. Ünal, C. Erem, K. Serçe, Ö.İleli. Metastatik Kitleleri Taklit Eden Fokal Hepatik Yağlı İnfiltrasyon. Journal of Turgut Özal Medical Center. 1995; 2(2): 196-98. 24- M. Ünal, C. Erem, E. Korkmaz, K. Serçe, M. Kul, A. Zibandeh. Postprandial insufficient emptying of the gallbladder in patients with hypotonic gastroptosis: Role of Ultrasonography. T J Med Sci. 1995;24 119-22. 25- Ş. Ulusoy, C. Erem, B. Kardeş, E. Ovalı, İ. Köksal, Z. Mocan. Kronik Hemodiyaliz Hastalarında HBsAg, anti HBs, anti HCV ve anti HIV Prevalansı. Mikrobiyoloji Bülteni. 1995; 29: 397-403. 26- Ş. Ulusoy, C. Erem, E. Ovalı, M. Yıldırım, M. Sönmez, MZ. Mocan, M. Telatar. Kronik Hemodiyaliz Hastalarında Diyaliz Esnasında ve Diyaliz Dışı Dönemde Nazal

23 Desmopressin'in (DDAVP) Hemostaz Üzerine Etkisi. Türk Hematoloji-Onkoloji Dergisi (THOD).1995; 5:134-142. 27- C. Erem, M. Sönmez, H. Kavgacı, MZ. Mocan, M. Telatar. Akut Böbrek Yetersizliğinde Komplikasyonlar ve Mortalite. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon Dergisi.1995; 2: 106-110. 28- M. Ünal, C. Erem, K. Serçe. Renal Involvement by Lymphoma As A Renal Mass. J Med Sci.1995; 15: 359-60. 29- C. Erem, Y. Bülbül, T. Özlü. Sarkoidoz. Sendrom. 1995;7:18-24. 30- C. Erem, Z. Mocan, M. Telatar, Ş. Ulusoy. Trabzon ve Yöresinde Gebelerde Guatr Prevalansı. Endokrinolojide Yönelişler. 1995; 4:20-23. 31- C. Erem, U. Onur, Z. Mocan, H. Gümele, M. Telatar. Kronik Hemodiyaliz Hastalarında Beyin Manyetik Rezonans Bulguları. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon Dergisi.1995; 3: 118-122. 32- M. Ünal, C. Erem, K. Yıldız, K. Serçe, M. Sönmez. Primary Splenic Lymphoma: Regional Multi-organ İnvasion. T J Med Sci. 1995;23:225-230. 33- M. Ünal, C. Erem, K. Serçe. The Pseudo '' Pseudokidney Sign '' Due To the Mesenteric Tumor. T J Med Sci. 1995;23:159-160. 34- M. Ünal, H. Dinç, K. Serçe, C. Erem, S. Yılmaz. Large Splenic Artery Aneurysm Simulating Pancreatic Tail Carcinoma on Computed Tomography. T J Med Sci.1995;23:247-248. 35- C. Erem, M. Telatar, Y. Uzun, S. Çelik. A case of Secondary Testicular Insufficiency ''Isolated Luteinizing Hormone Deficiency''.T J Med Sci. 1995;23:89-92. 36- M. Ünal, K. Serçe, C. Erem, E. Korkmaz, S. Mızrak, M. Kul. Baryumlu kolon incelemesinde spastik kolonun radyolojik tanı kriterleri. Tanısal ve Girişimsel Radyoloji. 1994; 1:143-147. 37- M. Ünal, T. Uslu, S. Yılmaz, M. Tosun, C. Erem, T. Özlü, K. Serçe. Romatizmal hastalıkların akciğer değişikliklerinde yüksek rezolüsyonlu BT. Tanısal ve Girişimsel Radyoloji. 1994; 1:138-142. 38- M. Ünal, C. Erem, K. Serçe. An Acute Leukemia Case Presenting with Acute Lung Disease on Computed Tomography. T J Med Sci 22 (1994) 203-204. 39- C. Erem, M. Tosun, M. Telatar, M. Güler, K. Serçe, AU. Turhan. Normokalsemi, Brown Tümörü ve Böbrek Taşları ile Seyreden Bir Primer Hiperparatiroidi Vakası. T Klin Tıp Bilimleri 94;14:72-77.

24 40- C. Erem, Ü. Tufan, Y. Yiğiter, H. Savaşkan. Sigara ve Kanser. MN DOKTOR 1994;2:286-291. 41- C. Tuncer, C. Erem, H. Efe, M. Gül. Tiroid ve Kalp. MN DOKTOR 1994;313-315. 42- C. Erem, C. Tuncer, H. Efe. Antioksidanlar ve Lipid Metabolizması. T Klin Kardiyoloji. 1994;7:121-124. 43- H. Kavgacı, C. Erem, Ş. Ulusoy, F. Aydın. Akut Böbrek Yetersizliğinin Etyopatogenezi. T Klin Tıp Bilimleri. 1994;14:235-238. 44- H. Kavgacı, C. Erem, M. Sönmez, F. Aydın. Esansiyel Amino Asitlerin Akut Böbrek Yetersizliği Tedavisindeki Yeri. T Klin Tıp Bilimleri. 1994;14:239-241. 45- C. Erem, C. Tuncer, R. Gündoğdu, B. Eryonucu. Gebelikte Hipertansiyon ve Tedavisi. Klin Tıp Bilimleri. 1994;14:173-178. 46- K. Kulan, Ö. Göldeli, M. Çetiner, C. Tuncer, C. Erem, B. Komsuoğlu. Yeni Gelişen Atriyal Fibrilasyonda İntravenöz Propafenon Tedavisi. Ankara Numune Hastanesi Tıp Dergisi. 1993;33:96-99. 47- Ö. Göldeli, K. Kulan, C. Erem, B. Komsuoğlu. Hemodiyalizin Kronik Böbrek Yetmezliğinde Sol Ventrikül Sistolik ve Diyastolik Fonksiyonlarına Etkisi. Ankara Numune Hastanesi Tıp Dergisi. 1993;33:123-127. 48- B. Çetinarslan, B. Komsuoğlu, C. Erem, B. Görçin, SŞ. Komsuoğlu, EL. Duman. Yaşlılarda Hipertansiyon Prevalansı ve Bazı Elektrokardiyografik Bulgular. Türk Kardiyol Dern Arş. 1993; 21:17-21. 49- V. Aydemir, C. Erem, H. Bozkaya, Z. Mocan. Trabzon ve Yöresinde Normal ve Guatrlı Gebelerde Tiroid Fonksiyon Testleri. Kadın Doğum Dergisi. 1993;9:161-165. 50- C. Erem, Z. Mocan, M. Telatar. Gebelikte Tiroid Fonksiyonları ve Ötiroid Guatr. T Klin Tıp Bilimleri. 1993; 13:211-214. 51- C. Erem, B. Komsuoğlu. Kronik Böbrek Yetersizliği Olan Hastalarda Kardiyovasküler Bozukluklar. Türk Kardiyol Dern Arş. 1993;21:48-55. 52- C. Erem, B. Çetinarslan, Ş. Ulusoy, B. Komsuoğlu. Sol Ventrikül Hipertrofisi. T Klin Kardiyoloji. 1993;6:142-149. 53- M. Kırnap, H. Kavgacı, C. Erem, E. Başar. Romatizmal hastalıklarda akciğer tutulumu. Karadeniz Tıp Dergisi. 1992; 5(3): 167-73. 54- B. Komsuoğlu, C. Erem, B. Çetinarslan, H. Kavgacı. Yaşlılarda Hipertansiyon. Türk Kardiyol Dern Arş. 1990;18223-230.

III- عروض المؤتمرات العلمية العروض الدولية

1- The prevalence of diabetes and associated risk factors among adult population in a Turkish population (Trabzon city). Irfan Nuhoglu, Cihangir Erem, Halil Onder Ersoz, Mustafa Kocak, Nadim Civan. Endocrine Abstracts, May 2015, Bioscientifica. DOI: 10.1530/endoabs.37.ep365

2- Evaluation of recurrence risk in differentiated thyroid cancer after treatment. Mustafa Kocak, Rahman Koseoglu, Bircan Sonmez, Serdar Turkyilmaz, Ismail Dogan, Halil Onder Ersoz, Cihangir Erem. Endocrine Abstracts (2015) 37 EP918 | DOI:  10.1530/endoabs.37.EP918

3- Amyloid goiter as an unusual presentation of primary systemic amyloidosis: A case report. Irfan Nuhoglu, Nadim Civan, Ozge Ucuncu, Mustafa Kocak, Hulya Coskun, Havva Turgutalp, Halil Onder Ersoz, Cihangir Erem. Endocrine Abstracts, April 2014, Bioscientifica. DOI: 10.1530/endoabs.35.p1001

4- Adrenocortical carcinoma: a review of four cases. Mustafa Kocak, Ozge Ucuncu, Nadim Civan, Hulya Coskun, Serdar Turkyilmaz, Halil Onder Ersoz, Cihangir Erem. Endocrine Abstracts, April 2014, Bioscientifica. DOI: 10.1530/endoabs.35.p522.

5- Ukinc K, Ersoz HO, Karahan C, Erem C, Eminagaoglu S, Hacihasanoglu AB, Yilmaz M, Kocak M Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Diabetologia 48(S1): A370;2005. 41st Annual Meeting of EASD. Athens–2005.

26 6- Ersoz HO, Ukinc K, Eminagaoglu S, Erem C, Karahan C, Hacihasanoglu AB, Kocak M. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia modified albumin. Diabetologia 48(S1): A409;2005. 41st Annual Meeting of EASD. Athens–2005. 7- Ukinc K, Ersoz HO, Erem C, Hacihasanoglu AB, Kocak M. Comparison of Acetylsalicylic Acid And Ibuprofen in Treatment of De Quervain’s Thyroiditis. page:197, P2-137. 7th European Congress of Endocrinology 2005 Göteborg-Sweden. 8- Ukinc K, Ersoz HO, Erem C, Hacihasanoglu AB, Kocak M. Diagnostic Value of ProstateSpecific Antigen (PSA) and Free Prostate Specific Antigen (fPSA) in Women With Ovulatory and Anovulatory Polycystic Ovary Syndrome. page:295, P3-177. 7th European Congress of Endocrinology 2005 Göteborg-Sweden. 9- Ukinc K, Ersoz HÖ, Hacihasanoglu A, Erem C, Telatar M. Effect of Obesity on bone mineral Dansity in Patients with Polycystic Over Syndrome. 13 th European Congress on Obesity, Praque, Czech Republic 26-29 May, 2004, Abstract book,T4: P4-069. 10- Turkish Viagra Study Group. An open, multicenter, flexible dose escalation study to evaluate the efficacy and safety of sildenafil citrate. International Congress of European Society for Sexual Medicine. 16-19 November 2003, İstanbul. 11- Erem C, Hacıhasanoglu A, Ersöz HÖ, Cinel A, Reis AK,.Işık AC, Sarı A, Ukinc K, Telatar M: Nonsyndromic familial adrenal and extraadrenal pheochromocytoma in a Turkish family. P0015 6th European Congress of Endocrinology 2003 Lyon-Fransa. 12- Ersöz HÖ, Ukinc K, Özdemir F, Tekelioglu Y, Kartı S, Erem C, Ovalı E, Telatar M: In vivo and in vitro effects of functional thyroid disorders on peripheral lymphocyte subsets: An immunological study. P0228. 6th European Congress of Endocrinology 2003 Lyon- Fransa.

27 13- Ersöz HÖ, Köse M, Ukinc K, Gündüz A, Hacıhasanoğlu A, Kartı SS, Erem C, Telatar M: Subcutaneous lyspro and intravenous regular İnsulin treatments are equally effective for the treatment of diabetic ketoacidosis. Diabetologia 46(S2): A267;2003. 18th International Diabetes Federation Congress 2003 Paris-Fransa. 14- Ersoz HÖ, Ukinç K, Baykan M, Erem C, Durmuş İ, Telatar M. The effect of low dose metoprolol in sibutramine treated obese patients. Int J Obes. 2002; 26 (Suppl 1):S151. 15- Erem C, Kartı SS, Ukinç K, Ersöz O, Hacıhasanoğlu A, Arslan C, Eren N, Telatar M. Blood coagulation and fibrinolysis in patients with hyperthyroidism. Abstracts of the 24 th congress of Endocrinology and Metabolic Diseases of Turkey Joint meeting with the American Association of Clinical Endocrinologists, Endocrine Practice Supplement for September/October 20001; p.2. 16- Erem C, Kartı SS, Ukinç K, Ersöz O, Hacıhasanoğlu A, Fidan S, Kandemir N, Telatar M. Blood coagulation and fibrinolytic activity in hypothyroidism. Abstracts of the 24 th congress of Endocrinology and Metabolic Diseases of Turkey Joint meeting with the American Association of Clinical Endocrinologists, Endocrine Practice Supplement for September/October 20001; p.31. 17- Erem C, Kartı SS, Ukinç K, Ersöz O, Hacıhasanoğlu A, Altun E, Deniz Ö, Telatar M. Blood coagulation and fibrinolysis parameters in type 2 diabetic patients with and without vascular complications. Abstracts of the 24 th congress of Endocrinology and Metabolic Diseases of Turkey Joint meeting with the American Association of Clinical Endocrinologists, Endocrine Practice Supplement for September/October 20001; p.51. 18- Ukinç K, Ersöz O, Erem C, Kartı SS, Telatar M.Effects of one year statin treatment an acute phase reactants and lipid parameters in type 2 diabetic patients. Abstracts of the 24 th congress of Endocrinology and Metabolic Diseases of Turkey Joint meeting with the American Association of Clinical Endocrinologists, Endocrine Practice Supplement for September/October 20001; p.50.

28 19- Ersöz HÖ, Çolak H, Ukinc K, Erem C, Telatar M: Evaluation of the information level of diabetic patients before and after education programe. 11th Balkan Congress of Endocrinology 2001 İstanbul-Türkiye. 20- Erem C, Ersöz O, E. Ovalı, Ukinç K,H. Kavgacı, Telatar M. Increased plasma levels of antithrombin III in patients with hyperthyroidism. Abstracts of the 23 th congress of Endocrinology and Metabolic Diseases of Turkey Joint Meeting with the European Federation of Endocrine Societies. Journal of Endocrşnol Investigation, Vol 23, Suppl. To No 7, 2000, p. 21- Erem C, Ersöz O, E. Ovalı, Ukinç K,H. Kavgacı, Telatar M. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without vascular complications. Abstracts of the 23 th congress of Endocrinology and Metabolic Diseases of Turkey Joint Meeting with the European Federation of Endocrine Societies. Journal of Endocrinol Investigation, Vol 23, Suppl. To No 7, 2000, p. 50 22- Erem C, Tanakol R, Alagöl F, Ömer B, Çetin Ö. Relationships of bone turnover parameters, endogenous hormones and vitamin D deficiency to hip fracture in postmenopausal elderly women. Abstracts of the 23 th congress of Endocrinology and Metabolic Diseases of Turkey Joint Meeting with the European Federation of Endocrine Societies. Journal of Endocrinol Investigation, Vol 23, Suppl. To No 7, 2000, p. 20 23- Ersöz O, Y. Tekelioğlu, Ukinç K, Erem C, E. Ovalı, Alterations of pheripheral lymphocyte subsets in hypothyroid patients and response to levothyroxine treatment. Abstracts of the 23 th congress of Endocrinology and Metabolic Diseases of Turkey Joint Meeting with the European Federation of Endocrine Societies. Journal of Endocrşnol Investigation, Vol 23, Suppl. To No 7, 2000, p.15 24- Sahin A, Ersoz H, Kavgaci H, Erem C. The eficacy of losartan treatment in hypertensive type 2 diabetic patients. Abstracts of the 23 th congress of Endocrinology and Metabolic

29 Diseases of Turkey Joint Meeting with the European Federation of Endocrine Societies. Journal of Endocrinol Investigation, Vol 23, Suppl. To No 7, 2000, p.51 25- H. Efe, O. Değer, C. Erem, A. Örem, Y. Aliyazıcıoğlu, S. Karahan, D. Kırcı. Relationships of MDA with Various Metabolic Parameters in Patients with Different Thyroid Hormone Status. International Congress on Free Radicals in Health and Disease. September 6-10, 1995, İstanbul, Turkey, P 145. 26- H. Efe, O. Değer, C. Y. Aliyazıcıoğlu, C. Erem, A. Örem, S. Yıldırmış. Relationships of MDA with Various Metabolic Parameters in Diabetic Patients. International Congress on Free Radicals in Health and Disease. September 6-10, 1995, İstanbul, Turkey. P 142.

العروض الوطنية

1- Ersöz Ş, Ükinç K, Ersöz HÖ, Erem C, Çobanoğlu Ü, Yılmaz B, Özoran Y. Akciğer adenokarsinomunun Tiroid bezine metastazı (Bir olgu Sunumu). S:151, P002. 1. Ulusal Sitopatoloji Kongresi 2006 Antalya P2. 2- Koçak M, Hacıhasanoğlu A, Ersöz Ş, Erem C, Akdoğan R, Ükinç K, Ersöz HÖ. Vaka Sunumu: Otoimmün poliendokrin Sendrom Tip 2 ve T Hücreli Lenfoma. S:125, P0137

29. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi 2006 Antalya. 3- Koçak M, Hacıhasanoğlu A, Erem C, Ükinç K, Kılıçarslan F, Beşli S, Ersöz HÖ. Vaka Sunumu: Otoimmün poliendokrin Sendromlu Olgularımız. S:125, P0138. 29. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi 2006 Antalya. 4- Koçak M, Erem C, Hacıhasanoğlu A, Değer O, Topbaş M, Ersöz HÖ, Ükinç K, Trabzon ilinde Hipertansiyon Prevalansı ve İlişkili Risk Faktörleri. S:89, P0051. 29. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi 2006 Antalya.

30 5- Ükinç K, Ersöz HÖ, Erem C, Avunduk A, Hacıhasanoğlu A, Fidan E. Diyabetik Ketoasidoz Koması Nedeniyle Acil Serviste Teşhis Edilen Akromegali Vakası. S:91, P48.

41. Ulusal Diyabet Kongresi 2005 Antalya. 6- Ükinç K, Ersöz HÖ, Karahan C, Erem C, Yılmaz M, Eminağaoğlu S, Hacıhasanoğlu A. Diyabetik Nefropatide Yeni Bir Risk Faktörü Olarak Metiltetrahidrofolat Redüktaz C677T Mutasyonu ve Hiperhomosisteinemi. S:52, SS09. 41. Ulusal Diyabet Kongresi 2005 Antalya (Sözlü bildiri) 7- Ükinç K, Eminağaoğlu S, Ersöz HÖ, Karahan C, Erem C, Hacıhasanoğlu A. Diyabetik Hastalarda Yaygın Endotelyal Hasar Ve İskeminin Yeni Bir Göstergesi: İskemi Modifiye Albumin. S:60, SS:25. 41. Ulusal Diyabet Kongresi 2005 Antalya (Sözlü bildiri) 8- Ükinç K, Ersöz HÖ, Erem C, Hacihasanoğlu A, Koçak M. Ovulatuvar Ve Anovulatuvar Polikistik Over Sendromunda Prostat Spesifik Antijen Ve Serbest Prostat Spesifik Antijen Düzeylerinin Tani Değerleri. 28. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi 2005 Antalya. 9- Hacıhasanoğlu A, Erem C, Cinel A, Ersöz Ö, Reis A, Ükinç K. Primer Hiperparatiroidi (PHP): 68 olgunun klinik ve laboratuvar özellikleri ve tedavi sonuçlarının değerlendirilmesi 28. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi 2005 Antalya. 10- Hacıhasanoglu A, Erem C, Ersöz HO, Ukinc K, Çinel A, Bektaş Ö, Reis A, Sarı A. Vaka Sunumu: Primer Hiperparatiroidi ile Birlikte Görülen Kemiğin Paget Hastalığı. 27. Ulusal Endokrinoloji ve Metabolizma Hastalıkları Kongresi. 16-18 Eylül 2004 İstanbul, Sözel ve Poster özetleri kitabı sayfa 34, P7. 11- Ukinc K, Ersoz HÖ, Erem C, Hacihasanoğlu AB, Alhan E, Çoban Ü, Bektaş Ö. Vaka Sunumu: Nörofibromatoz Tip 1 (Von Recklinghausen Hastalığı) ve Feokromositoma. 27.

31 Ulusal Endokrinoloji ve Metabolizma Hastalıkları Kongresi. 16-18 Eylül 2004 İstanbul, Sözel ve Poster özetleri kitabı sayfa 34, P6. 12- Ukinc K, Ersoz HÖ, Erem C, Hacihasanoğlu AB, Koçak M, Birol S. Diyabetik Hastaların tedavisinde ne kadar hedefteyiz? 27. Ulusal Endokrinoloji ve Metabolizma Hastalıkları Kongresi. 16-18 Eylül 2004 İstanbul, Sözel ve Poster özetleri kitabı sayfa 35, P8. 13- Ukinc K, Erem C, Ersoz HÖ, Hacihasanoğlu AB, Koçak M, Birol S. Ağrılı Subakut Tiroiditli Olgularımızın Klinik, Laboratuar ve Tedavi Sonuçlarının Değerlendirilmesi. 27. Ulusal Endokrinoloji ve Metabolizma Hastalıkları Kongresi. 16-18 Eylül 2004 İstanbul, Sözel ve Poster özetleri kitabı sayfa 35, P9. 14- Ersöz HÖ, Köse M, Ükinç K, Gündüz A, Hacıhasanoğlu A, Kartı S, Erem C, Telatar M: Diyabetik ketoasidozda subkütan insülin lispro ve intravenöz kristalize insülin tedavilerinin karşılaştırılması: Randomize kontrollü çalışma. s:39, SS19. 39. Ulusal Diyabet Kongresi 2003 İstanbul (Sözlü bildiri). 15- Ükinç K, Ersöz HÖ, Hacıhasanoğlu AB, Erem C, Telatar M: Hirşutizm olgularında kemik yoğunluğunun vücut kompozisyonu ve androjenik belirteçlerle ilişkisi. Turkish J Endoc Metab Vol:7, Supp:1,p:111, SS10. 21 26. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi 2003 Adana (Sözlü bildiri). 16- Ükinç K, Ersöz HÖ, Hacıhasanoğlu AB, Erem C, Telatar M: Hirşutizmli olgularda kardiyo vasküler risk faktörlerinin değerlendirilmesi. Turkish J Endoc Metab Vol:7, Supp:1,p:111, SS11. 26. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi 2003 Adana (Sözlü bildiri). 17- Ersöz HÖ, Ükinc K, Baykan M, Erem C, Durmuş İ, Hacıhasanoğlu A, Telatar M: Normotansif obez hastalarda diurnal kan basıncı varyasyonu ve kardiyovasküler risk faktörleri ile ilişkisi. s:81, SS4/12. Türk Obezite Kongresi 2002 Antalya (Sözlü bildiri).

32 18- C. Erem, A. Hacıhasanoğlu, A. Cinel Ö. Ersöz, AK. Reis, M. Köse, K. Ukinç, M. Telatar. Sfenoid sinüs brown tümörü, oksipital kemikte kitle ve hiperkalsemi: Primer hiperparatiroidinin nadir bir prezantasyonu. 25. Ulusal Endokrinoloji ve Metabolizma Hastalıkları Kongresi. 18-22 Eylül 2002 Erzurum, Poster özetleri kitabı sayfa 40. 19- C. Erem, A. Hacıhasanoğlu, A. Cinel Ö. Ersöz, AK. Reis, K. Ukinç, M. Telatar. Primer Hiperparatiroidi. 26 olgunun klinik ve laboratuvar özellikleri ve tedavi sonuçlarının değerlendirilmesi. 25. Ulusal Endokrinoloji ve Metabolizma Hastalıkları Kongresi. 18-22 Eylül 2002 Erzurum, Poster özetleri kitabı sayfa 40. 20- HÖ. Ersöz, K. Ukinç, M. Baykan, C. Erem, İ. Durmuş, A. Hacıhasanoğlu, M. Telatar. Obezite tedavisinde sibutramin ve düşük doz kardiyoselektif betablokör kombinasyonunun etkinliği. 25. Ulusal Endokrinoloji ve Metabolizma Hastalıkları Kongresi. 18-22 Eylül 2002 Erzurum, Poster özetleri kitabı sayfa 61. 21- K. Ukinç, A. Hacıhasanoğlu, B. Yılmazer, HÖ. Ersöz, C. Erem, M. Telatar. Diyabetik hastalarda tedavi sonuçlarının değerlendirilmesi. 25. Ulusal Endokrinoloji ve Metabolizma Hastalıkları Kongresi. 18-22 Eylül 2002 Erzurum, Poster özetleri kitabı sayfa 27. 22- HÖ. Ersöz, K. Ukinç, M. Baykan, C. Erem, İ. Durmuş, M. Telatar. Normotensif obez hastalarda diürnal kan basıncı varyasyonu ve kardiyovasküler risk faktörleri ile ilişkisi. 2002 Türk Obezite Kongresi, 24-27 Nisan 2002 Antalya. Bildiri Kitabı, Sayfa: 81. 23- K. Ukinç, HÖ. Ersöz, C. Erem, S. Kartı, M. Telatar. Diyabetik hastalarda mikro ve makrovasküler komplikasyonların göstergesi olarak CRP, fibrinojen ve ferritin düzeyleri. XXXVII. Ulusal Diyabet kongresi, 21-25 Mayıs 2001, Program Bildiri Özetleri Kitabı sayfa 60. 24- Ükinç K, Hocaoğlu Ç, Eren N, Sayar K, Ersöz HÖ, Erem C, Telatar M: Bir faktisyöz hipoglisemi olgusu. s:144, PS10/88. 37. Ulusal Diyabet Kongresi 2001 Aydın. 25- A. Reis, Ü. Çobanoğlu, C. Erem. Adrenal Feokromositoma (Olgu Sunumu). XV. Ulusal Patoloji Sempozyumu, Cerrahi Patolojide Ayırıcı Tanı. 24-27 Mayı 2000, Belek/Antalya, Program Bildiri Özetleri kitabı sayfa 224. 26- HÖ. Ersöz, Y. Tekelioğlu, K. Ukinç, C. Erem, E. Ovalı. Hipotiroidili hastalarda periferik kanda lenfosit alt grupları. 1. Türkiye Tiroid Hastalıkları Kongresi, 2-3 Haziran 2000, İstanbul, Bildiri Özetleri Kitabı sayfa 102.

33 27- Ersöz HÖ, Çolak H, Ükinç K, Erem C. Diyabetik hastalarda, hasta eğitim programı öncesi ve sonrasında, bilgi düzeylerinin değerlendirilmesi. D/P12. XXXVI. Ulusal Diyabet Kongresi 2000 Gaziantep. 28- L. Erdemli, C. Erem, F. Özdemir, H. Kavgacı, S. Kapıcıoğlu. Guatrlı gebelerde serum bakır düzeyi. 22 nd Congress of Endocrinology and Metabolic Diseases of Turkey and Postgraduate Training Courses, 19-23 Ekim 1999, Antalya, sayfa 90. 29- C. Erem, N. Cihanyurdu, H. Kavgacı, M. Telatar, S. Kapıcıoğlu. Trabzon İl Merkezinde Gestasyonel Diabetes mellitus Prevalansı. XXXV. Ulusal Diyabet Kongresi ve IV. Uluslararası Obezite Sempozyumu. 10-15 Mayıs 1999, İstanbul, Bildiri Kitabı sayfa: 16. 30- Erem C, Algün E, Özbey N, Azezli A, Aral F, Orhan Y, Molvalılar S, Sencer E. Cushing sendromu: kırk beş olgunun klinik ve laboratuvar bulguları ve tedavi sonuçları ile değerlendirilmesi. XXI. Ulusal Endokrinoloji ve Metabolizma Hastalıkları Kongresi 29 Eylül-3 Ekim 1998, İstanbul, Kongre Program ve Özet kitabı sayfa 225. 31- Aral F, Özbey N, Azezli A, Kahraman H, Algün E, Erem C, Orhan Y, Molvalılar S, Sencer E. Prolaktinomalı hastalarımızda tedavinin değerlendirilmesi. XXI. Ulusal Endokrinoloji ve Metabolizma Hastalıkları Kongresi 29 Eylül-3 Ekim 1998, İstanbul, Kongre Program ve Özet kitabı sayfa 136. 32- C.Erem, R. Tanakol, M. Adaş, S. Yarman, H. Oğuz, F. Alagöl. Kronik Hemodiyaliz hastalarında yumuşak doku kalsifikasyonu ve periartiküler tümöral kalsinoz. XX. Ulusal Endokrinoloji ve Metabolizma Hastalıklları Kongresi 23-27 Eylül 1997, İzmir, Kongre Program ve Özet kitabı sayfa 189. 33- R. Tanakol, M. Adaş, C.Erem, S. Yarman, H. Oğuz, F. Alagöl. Subklinik hipotiroidi: Bir hastalık mı yoksa basit bir biyokimyasal anormallik mi?. XX. Ulusal Endokrinoloji ve Metabolizma Hastalıklları Kongresi 23-27 Eylül 1997, İzmir, Kongre Program ve Özet kitabı sayfa 119. 34- C. Erem, R. Yıldız, M. Ünal, Ş. Ulusoy, M. Sönmez, M. Telatar. Primer Boş Sella Sendromu ve İntermitan Diabetes İnsipidus. Uluslararası Katılımlı 19. Ulusal Endokrinoloji-Diyabetoloji ve Endokrin Cerrahisi Kongresi. 28-31 Mayıs 1996, İstanbul. 35- C. Erem, F. Çağılcı, C. Karahan, M. Sönmez, Ş. Ulusoy, M. Telatar, R. Yıldız. Vasküler Komplikasyonlu ve Vasküler Komplikasyonsuz Tip II Diabetes Mellituslu Hastalarda Plazma Lipoprotein (a) Seviyeleri. Uluslararası Katılımlı 19. Ulusal

34 Endokrinoloji-Diyabetoloji ve Endokrin Cerrahisi Kongresi. 28-31 Mayıs 1996, İstanbul. 36- C. Erem, H. Savaşkan, Ş. Ulusoy, M. Sönmez, R. Yıldız, M. Telatar. Böbrek Taşları ve Kafa Grafisinde Tuz-biber Görünümü ile Seyreden Bir Primer Hiperparatiroidi Vakası. K.T.Ü Tıp Fakültesi V. Karadeniz Tıp Günleri 27-30 Mayıs 1996 Trabzon. 37- Ş. Ulusoy, R. Yıldız, C.Erem, M. Sönmez, H. Savaşkan, S. Gül. Down Sendromu ve Akut Lösemi. K.T.Ü Tıp Fakültesi V. Karadeniz Tıp Günleri 27-30 Mayıs 1996 Trabzon. 38- C. Erem, M. Telatar, H. Savaşkan, O. Değer, C. Karahan, M. Sönmez, Ş. Ulusoy. Tip II Diabetes Mellitus'lu Hastalarda Plazma Endotelin-1 Seviyeleri.Ulusal Diabet Kongresi ve İnsülinin Keşfine Doğru 75. Yıl Sempozyumu.17-21 Mayıs 1995 Kayseri / Kapadokya. 39- C. Erem, H. Kavgacı, MZ. Mocan, Ş. Ulusoy. Akut Böbrek Yetersizliği Tedavisinde Esansiyel Aminoasitlerin Etkisi. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon Kongresi Bildiri Özetleri (s.4) 11-14 Ekim 1994 Samsun. 40- C. Erem, E. Akyılmaz, E. Ovalı, Z. Mocan. Akut Böbrek Yetersizliği Olan Hastalarda İdrar Endotelin Ekskresyonu. Ulusal Böbrek Hastalıkları, Diyaliz ve Transplantasyon Kongresi Bildiri Özetleri (s.104) 11-14 Ekim 1994 Samsun. 41- C. Erem, Z. Mocan, M. Yıldırım, M. Telatar, O. Değer. Tip II Diabetes Mellitus Nefropatisinin Erken Tanısında Beta-2-Mikroglobulin ve N-Asetil-B-D- Glukozaminidaz Enzim Aktivitesinin Karşılaştırılması. Ulusal Diabet Kongresi. 4-7 Mayıs 1994, İzmir. 42- E. Ovalı, H. Kavgacı, M. Çetiner, M. Sönmez, C. Erem, F. Aydın, M. Telatar. Bir İnsülinoma Olgusunda Verapamil, Somatostatin ve Cerrahi Tedavi Sonuçlarının Karşılaştırılması. I. Uluslararası Hipoglisemi ve Endokrinoloji Sempozyumu Poster Özetleri 6-7 Mayıs 1993-İstanbul. 43- F. Aydın, Ş. Ulusoy, H. Kavgacı, E. Ovalı, C. Erem. Uygunsuz ADH Sendromunda Sıvı Kısıtlamasının Sonuçları. II. Karadeniz Tıp Günleri Bildiri Özetleri 25-27 Mayıs 1993-Trabzon. 44- B. Komsuoğlu, Ş. Ulusoy, H. Kavgacı, C. Erem, B. Görçin. Esansiyel Hipertansiyonlu Yaşlı Olgularda Ventriküler Aritmileri Üzerine Diüretik Tedavinin Etkileri. Türk Kardiyoloji Derneği Arşivi Kardiyoloji Toplantısı Bildiri Özetleri (s.65) 10-13 Eylül 1991-Trabzon.

IV- تأليف فصول في كتب دولية

1- Cihangir Erem. Ganglioneuroma: An overview. Tumors of the Central Nervous System, Volume 9: Lymphoma, Supratentorial Tumors, Glioneuronal Tumors, Gangliogliomas, Neuroblastoma in Adults, Astrocytomas, Ependymomas, Hemangiomas, and Craniopharyngiomas. Editor: M.A. Hayat. Springer Science & Business Media. Dordrecht, Heidelberg, New York, London, 2012, p.137-146.

IV- تأليف فصول في كتب وطنية

1- Cihangir Erem. Feokromositoma. Endokrinoloji ve Metabolizma. Editör: Prof. Dr. Metin Özata. İstanbul Medikal Yayıncılık Hiz. Tic. Ltd. Şti., İstanbul, 3. Baskı, 2016, Sayfa: 351-372.